Electronic Nose Sniffs Out Prostate Cancer Using Urine Samples innovationtoronto.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from innovationtoronto.com Daily Mail and Mail on Sunday newspapers.
Xeltis Announces Latest Results from aXess Trials to be Presented at 46th Annual Charing Cross Symposium Two key presentations by leading KOLs highlight positive results from aXess trials in adult patients with end-stage renal disease who need vascular access to hemodialysisaXess is a restorative arteriovenous.
Findings from Department of Vascular Surgery Yields New Data on Thrombosis (A Comparison of Venaseal Versus Radiofrequency Ablation Outcomes Within a Managed Care Organization): Cardiovascular Diseases and Conditions - Thrombosis - Insurance News insurancenewsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancenewsnet.com Daily Mail and Mail on Sunday newspapers.
Outstanding 12-Month First-In-Human Data From Xeltis' Axess Hemodialysis Vascular Conduit Trial Presented At Veithsymposium 2023 menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
Outstanding 12-month first-in-human data from Xeltis’ aXess hemodialysis vascular conduit trial presented at VEITHsymposium 2023 aXess demonstrated exceptional patency rates and no infections to date EINDHOVEN, The Netherlands – 17 November 2023, Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, announces outstanding 12-month data from its first-in-human (FIH) aXess vascular conduit trial (NCT04898153). The data was presen